Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Revolution Medicines Inc (RVMD)

681 + Investors. Track Smart Money conviction in RVMD. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +176
Streak
11Q ▲
Buyers last Q
68%

Smart Money Signals — RVMD

Based on 694 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 11 quarters in a row

last 6Q
For 11 consecutive quarters, more hedge funds added RVMD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
694 hedge funds hold RVMD right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +128% more funds vs a year ago

fund count last 6Q
+390 new funds entered over the past year (+128% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 68% buying

490 buying229 selling
Last quarter: 490 funds were net buyers (245 opened a brand new position + 245 added to an existing one). Only 229 were sellers (160 trimmed + 69 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+73 vs last Q)

new funds entering per quarter
Funds opening a new RVMD position: 62 → 109 → 172 → 245. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄

Mostly new holders — 55% entered in last year

24% conviction (2yr+) 21% medium 55% new
Only 165 funds (24%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +95% but shares only +20% — price-driven

Value
+95%
Shares
+20%
Last quarter: the total dollar value of institutional holdings rose +95%, but actual share count only changed +20%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

60 → 62 → 109 → 172 → 245 new funds/Q
New funds entering each quarter: 62 → 109 → 172 → 245. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🌱

Early stage — 57% of holders entered in last year

31% veterans 12% 1-2yr 57% new
Of 727 current holders: 415 (57%) entered in the past year, only 223 (31%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
🏆

Elite ownership — 40% AUM from top-100 funds

40% from top-100 AUM funds
64 of 686 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in RVMD. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
6.0
out of 10
Moderate Exit Risk
Exit risk score 6.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — RVMD

In 2026 Q2, 490 hedge funds were net buyers of RVMD (245 opened a new position, 245 added to an existing one), while 229 reduced or exited (160 trimmed, 69 sold completely) — a 68% buyer ratio, indicating clear institutional accumulation. This marks 11 consecutive quarters of net institutional buying — a persistent conviction signal. 40% of total institutional value in RVMD is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +176 funds (more new holders than closures). Total institutional holders: 694.

Hedge Fund Ownership: RVMD

How many hedge funds hold RVMD — quarterly history vs. share price
Quarterly hedge fund ownership of RVMD vs. share price

Market Analysis: RVMD

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: RVMD

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Growing Institutional Interest

Quality funds are building positions — conviction is rising but not yet widespread.

28 top-rated funds 36 high-conviction
Consensus
6.3
/ 10
breadth
×
Elite
6.9
/ 10
conviction
Hedge Fund Positioning: RVMD
681 + Investors

Track Smart Money conviction in RVMD. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 681 518 31.47%
13F Shares 205M 208M -1.23%
Total Value $37.53B $19.37B 93.72%
New Positions 242 172 +70
Increased Positions 233 169 +64
Closed Positions 71 40 +31
Reduced Positions 155 127 +28
Total Calls 23 20 15.0%
Total Puts 18 26 -30.77%
PUT/CALL Ratio 0.78 1.3 Neutral

Statistics: RVMD

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

681 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in RVMD. Verified SEC 13F-HR filings.

QUARTER:
Top 25 RVMD holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Nextech Invest Ltd. 67.55% 7,601,087 $1.42B
2 AIHC Capital Management Ltd 54.46% 303,133 $56.8M
3 Darwin Global Management, Ltd. 54.45% 10,629,822 $2.05B
4 MIC Capital Management UK LLP 25.25% 531,733 $99.6M
5 Casdin Capital, LLC 24.16% 2,577,333 $482.7M
6 Paradigm Biocapital Advisors LP 22.31% 6,361,323 $1.19B
7 DAFNA Capital Management LLC 20.09% 562,630 $105.4M
8 Checkpoint Capital L.P. 19.72% 410,353 $76.9M
9 Mass General Brigham, Inc 17.85% 344,091 $64.4M
10 Caligan Partners LP 17.28% 1,961,795 $367.4M
11 Bvf Inc/Il 14.20% 2,965,160 $555.3M
12 Integral Health Asset Management, LLC 11.10% 1,500,000 $280.9M
13 Baker BROS. Advisors LP 10.74% 11,443,357 $2.14B
14 Rock Springs Capital Management LP 10.10% 1,105,210 $207.0M
15 First Turn Management, LLC 8.32% 415,307 $77.8M
16 Patient Square Capital LP 8.01% 276,000 $51.7M
17 Seven Fleet Capital Management LP 7.48% 242,029 $45.3M
18 Boxer Capital Management, LLC 7.05% 500,000 $93.6M
19 Nearwater Capital Markets, Ltd 6.77% 2,097,000 $392.7M
20 Artia Global Partners LP 6.41% 185,390 $34.7M
21 Superstring Capital Management LP 6.04% 51,053 $9.6M
22 Logos Global Management LP 5.64% 700,000 $131.1M
23 MPM BioImpact LLC 5.62% 492,483 $92.2M
24 Stempoint Capital LP 5.16% 159,943 $30.0M
25 Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.91% 479,080 $89.7M
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Revolution Medicines Inc (RVMD)

What does the Smart Money Trend signal show for RVMD?

Buying streak — 11 quarters in a row: For 11 consecutive quarters, more hedge funds added RVMD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for RVMD?

More buyers than sellers — 68% buying: Last quarter: 490 funds were net buyers (245 opened a brand new position + 245 added to an existing one). Only 229 were sellers (160 trimmed + 69 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for RVMD holders?

Elite ownership — 40% AUM from top-100 funds: 64 of 686 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in RVMD. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held RVMD?

Mostly new holders — 55% entered in last year: Only 165 funds (24%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →